Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
Biodiversity-derived protein data and AI models for biological design
Basecamp Research is a London-based biotech company that collects biological samples from extreme environments across more than 26 countries, building a proprietary metagenomic database of over ten billion novel protein sequences from more than one million previously unrecorded species. This dataset trains large AI…
Deep-UV sensors for continuous microbial water monitoring
Orb develops optical sensors and analytical software for monitoring microbial changes in water systems. Its in-line probes use deep-ultraviolet autofluorescence to measure biological signatures in drinking and process water, providing continuous trends rather than relying exclusively on periodic laboratory sampling. A…
Drug discovery platform targeting biomolecular condensates
Transition Bio is a biotechnology company developing a drug discovery platform based on the biology of biomolecular condensates, the membrane-less cellular structures implicated in a range of diseases. Using droplet microfluidics and machine learning, the company maps and modulates condensate behaviour to identify…
Brain-inspired AI platform for multi-target drug discovery
Symbiotic.blue is a pre-seed biotech company developing an AI-driven drug discovery platform that combines generative AI with neuroscience-inspired computational methods. The platform aims to design molecules capable of acting on multiple biological targets simultaneously, with an initial focus on obesity. The company…
Generative AI platform for TCR therapy design and immune repertoire analysis
Synteny Biotechnology is a biotechnology company developing a platform that combines high-throughput TCR-antigen data generation with generative AI to design precision T cell receptor therapies for cancer. The platform addresses a critical bottleneck in the field, namely the scarcity of paired TCR-epitope interaction…
Clinical-stage CNS drug discovery using human brain genomics
Cerevance is a clinical-stage biotechnology company developing small molecule therapeutics for neurodegenerative and psychiatric disorders. The company uses its proprietary platform to profile gene expression in specific neuronal and glial cell types from a collection of over 16,000 annotated human brain tissue…
AI-designed protein fibres as sustainable alternatives to synthetic textiles
Solena Materials is an industrial biotechnology company developing a new class of protein-based fibres for the fashion and performance apparel sectors. Using proprietary deep learning models and computational protein design, the company engineers novel proteins from first principles, which are then produced using…
Real-time cell aggregate monitoring for stem cell manufacturing
MorphoKinetics is a life science instrumentation company developing real-time monitoring technology for stem cell manufacturing. Its process analytical platform combines automated sampling, machine vision and artificial intelligence to measure the size, shape and growth of cell aggregates in bioreactor cultures. The…
Real-world mental health and dementia data platform for drug development
Akrivia Health is a software company providing a real-world data and AI platform for neuroscience research and drug development. Its dataset of de-identified electronic health records from 6.3 million patients across 20 NHS Trusts covers mental health and dementia conditions, enriched through proprietary natural…
Genetically diverse iPSC models and high-throughput drug screening
Cytochroma is an Edinburgh biotechnology company producing genetically diverse human induced pluripotent stem cell-derived models for drug discovery and safety research. Its donor-matched panels include hepatocytes, cardiomyocytes and supporting cell types, enabling assessment of drug responses across different…
AI-powered portable diagnostics platform for field-based disease testing
Vidiia is a diagnostics company developing AI-powered, portable molecular testing devices for point-of-care and field-based disease detection. Its platform combines RT-LAMP assay chemistry with smartphone-connected artificial intelligence to interpret results, and has received UK regulatory approval for medical use.…
AI-controlled modular aquaculture for local seafood production
Raygonal develops Aquary, a modular, AI-assisted system for land-based aquaculture and local seafood production. The platform integrates water management, environmental monitoring, automation and renewable energy to support controlled cultivation of fish, including tropical species. The company is piloting its system…
Collaborative AI and multi-omics software for translational research
Vedaly is a scientific software company developing collaborative AI and bioinformatics tools for translational research and biopharmaceutical development. Its platform brings together omics, clinical and experimental data, analysis results, figures and scientific literature in traceable research workflows. It supports…
Directed evolution platform engineering microbes for industrial biomanufacturing
Evolutor is a biotechnology company developing directed evolution technologies to enhance microbial performance for industrial biomanufacturing. Its proprietary genetic toolbox links bacterial cell fitness to recombinant protein production rates, generating evolved production strains with substantially improved…
AI platform generating novel therapeutic proteins for biotech partners
Latent Labs is a UK-based developer of artificial intelligence models that generate entirely new therapeutic proteins not found in nature. Building on foundational AI protein-structure research, the company's platform designs proteins tailored to specific biological functions, aiming to expand the range of diseases…
AI-driven neural data platform for bioelectronic medicine
BIOS Health is a neural engineering company developing an AI-powered platform that reads and interprets peripheral nervous system signals in real time. Its technology links nerve activity to physiological conditions through the discovery of neural biomarkers, supporting the development of personalised neuromodulation…
AI-powered infrared diagnostic test for breast cancer recurrence risk
Digistain is a biotechnology company developing MHRA-cleared diagnostic technology for predicting breast cancer recurrence risk. The platform uses infrared spectrometry to generate spectroscopic signatures from tumour biopsy tissue, with AI analysis producing a personalised prognostic score indicating the likelihood…
AI-powered rare disease case finding for primary care
Mendelian is a digital health software company developing AI-driven tools to support the earlier diagnosis of rare diseases in primary care. Its core product is a Class 1 regulated medical device that analyses electronic health records to identify patients whose symptom profiles are consistent with published…
Nanopore platform for single-molecule full-length protein sequencing
Portal Biotech is a biotechnology company developing benchtop nanopore instruments for single-molecule proteomics and metabolomics. Its platform uses bioengineered nanopores coupled with machine learning to sequence intact, full-length proteins at the single-molecule level, capturing protein mutations, modifications…
ML-guided strain engineering to optimise precision fermentation yields
Eden Genetics is a biotechnology company using machine learning to improve recombinant protein production through microbial strain engineering. Its computational platform analyses genetic and fermentation data to identify modifications intended to increase protein secretion and productivity in precision-fermentation…